A mechanistic model of tau amyloid aggregation based on direct observation of oligomers

Nature Communications

Volumn 6, Issue , 2015, Pages

  Shammas, Sarah L ^a   Garcia, Gonzalo A ^a   Kumar, Satish ^b,e   Kjaergaard, Magnus ^a,f   Horrocks, Mathew H ^a   Shivji, Nadia ^a   Mandelkow, Eva ^b,c   Knowles, Tuomas P J ^a   Mandelkow, Eckhard ^b,c,d   Klenerman, David ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^d MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^e GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; OLIGOMER; TAU PROTEIN;

MUTATION; NEUROLOGY; PROTEIN; REACTION KINETICS; TOXICITY;

ARTICLE; CYTOTOXICITY; DEGENERATIVE DISEASE; DELETION MUTANT; ENERGY; FAMILIAL DISEASE; FLUORESCENCE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; KINETICS; MOLECULE; PAIRED HELICAL FILAMENT; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DOMAIN; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; METABOLISM; MUTATION; PROTEINOSIS;

AMYLOID; HUMANS; KINETICS; MODELS, BIOLOGICAL; MUTATION; PROTEIN AGGREGATION, PATHOLOGICAL; TAU PROTEINS;

EID: 84928792132     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8025     Document Type: Article

References (44)

1. Irwin, D. J., Lee, V. M. Y. & Trojanowski, J. Q. Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat. Rev. Neurosci. 14, 626-636 (2013).
2. Lee, V. M. Y., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (2001).
3. Barghorn, S., Davies, P. & Mandelkow, E. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain. Biochemistry 43, 1694-1703 (2004).
4. Dehmelt, L. & Halpain, S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6, 204 (2005).
5. Avila, J., Lucas, J. J., Perez, M. & Hernandez, F. Role of tau protein in both physiological and pathological conditions. Physiol. Rev. 84, 361-384 (2004).
6. Jeganathan, S., von Bergen, M., Mandelkow, E. M. & Mandelkow, E. The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments. Biochemistry 47, 10526-10539 (2008).
7. Santarella, R. A. et al. Surface-decoration of microtubules by human Tau. J. Mol. Biol. 339, 539-553 (2004).
8. von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta 1739, 158-166 (2005).
9. Daebel, V. et al. beta-sheet core of tau paired helical filaments revealed by solidstate NMR. J. Am. Chem. Soc. 134, 13982-13989 (2012).
10. Barghorn, S. & Mandelkow, E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41, 14885-14896 (2002).
11. Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Domains of Tau-protein and interactions with microtubules. Biochemistry 33, 9511-9522 (1994).
12. Goedert, M. et al. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553 (1996).
13. Kampers, T., Friedhoff, P., Biernat, J. & Mandelkow, E. M. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399, 344-349 (1996).
14. Ramachandran, G. & Udgaonkar, J. B. Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by tau protein. J. Biol. Chem. 286, 38948-38959 (2011).
15. Bemporad, F. & Chiti, F. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem. Biol. 19, 315-327 (2012).
16. Knowles, T. P. J. et al. An analytical solution to the kinetics of breakable filament assembly. Science 326, 1533-1537 (2009).
17. Cohen, S. I. A. et al. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J. Chem. Phys. 135, 065105 (2011).
18. Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of alpha-synuclein. Cell 149, 1048-1059 (2012).
19. Rizzu, P. et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet. 64, 414-421 (1999).
20. Barghorn, S. et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39, 11714-11721 (2000).
21. Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405 (2000).
22. Horrocks, M. H. et al. Single Molecule Fluorescence under Conditions of Fast Flow. Anal. Chem. 84, 179-185 (2012).
23. von Bergen, M. et al. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local betastructure. J. Biol. Chem. 276, 48165-48174 (2001).
24. Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Guerrero-Munoz, M. J., Jackson, G. R. & Kayed, R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039-10041 (2010).
25. Lasagna-Reeves, C. A. et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol. Neurodegener. 6, 39 (2011).
26. Lasagna-Reeves, C. A. et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci. Rep. 2, 700 (2012).
27. Oosawa, F. & Asakura, S. Thermodynamics Of The Polymerization Of Protein (Academic Press, 1975).
28. Oosawa, F. & Kasai, M. Theory of linear and helical aggregations of macromolecules. J. Mol. Biol. 4, 10-21 (1962).
29. Kumar, S. et al. Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity. J. Biol. Chem. 289, 20318-20332 (2014).
30. Eckermann, K. et al. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J. Biol. Chem. 282, 31755-31765 (2007).
31. Mocanu, M. M. et al. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748 (2008).
32. Aoyagi, H., Hasegawa, M. & Tamaoka, A. Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J. Biol. Chem. 282, 20309-20318 (2007).
33. Chang, E. & Kuret, J. Detection and quantification of tau aggregation using a membrane filter assay. Anal. Biochem. 373, 330-336 (2008).
34. Combs, B. & Gamblin, T. C. FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions. Biochemistry 51, 8597-8607 (2012).
35. Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M. & Margittai, M. Variations in filament conformation dictate seeding barrier between three-and four-repeat tau. Biochemistry 50, 4330-4336 (2011).
36. Frost, B., Ollesch, J., Wille, H. & Diamond, M. I. Conformational diversity of wild-type tau fibrils specified by templated conformation change. J. Biol. Chem. 284, 3546-3551 (2009).
37. Mohamed, N. V., Herrou, T., Plouffe, V., Piperno, N. & Leclerc, N. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission. Eur. J. Neurosci. 37, 1939-1948 (2013).
38. Frost, B. & Diamond, M. I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159 (2010).
39. Orte, A., Clarke, R., Balasubramanian, S. & Klenerman, D. Determination of the fraction and stoichiometry of femtomolar levels of biomolecular complexes in an excess of monomer using single-molecule, two-color coincidence detection. Anal. Chem. 78, 7707-7715 (2006).
40. Narayan, P. et al. Single molecule characterization of the interactions between amyloid-beta peptides and the membranes of hippocampal cells. J. Am. Chem. Soc. 135, 1491-1498 (2013).
41. Cohen, S. I. A. et al. Proliferation of amyloid-beta 42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl Acad. Sci. USA 110, 9758-9763 (2013).
42. Ferrone, F. A., Hofrichter, J. & Eaton, W. A. Kinetics of sickle hemoglobin polymerization. 2. A double nucleation mechanism. J. Mol Biol. 183, 611-631 (1985).
43. von Bergen, M. et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc. Natl Acad. Sci. USA 97, 5129-5134 (2000).
44. Fersht, A. Structure And Mechanism In Protein Science: A Guide To Enzyme Catalysis And Protein Folding, edn. 3 (W. H. Freeman & Co Ltd., New York, USA, 1999).